Dec 18, 2023 Report of the Educational Meeting on Immunology and Cellular Therapy in Plasma Cell Disorders - 24-26 November 2023 - Hamburg, Germany
Dec 11, 2023 FDA Reports of Secondary Malignancies Following Chimeric Antigen Receptor (CAR) T Cell Therapies and Relative Risk: an EBMT-EHA-GoCART Coalition Statement